01 1Merck Canada Inc.
02 1Merck Frosst Canada Ltd
01 22183250
01 2Fosaprepitant dimeglumine
01 1Lyophilized powder
02 1Powder for solution
01 22015-02-28
Patent Expiration Date : 2015-02-28
Date Granted : 2006-03-21
Brand Name : EMEND IV
Patent Number : 2183250
Filing Date : 1995-02-28
Strength per Unit : 115 mg / vial
Dosage Form : Lyophilized powder
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-02-28
Date Granted : 2006-03-21
Patent Expiration Date : 2015-02-28
Date Granted : 2006-03-21
Brand Name : EMEND IV
Patent Number : 2183250
Filing Date : 1995-02-28
Strength per Unit : 150 mg
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-02-28
Date Granted : 2006-03-21
LOOKING FOR A SUPPLIER?